Onelin Capital Corporation
Seattle, Washingtononelincapital.com
Overview
Onelin Capital Corporation (OCC) is a Seattle and Silicon Valley-based multi-asset strategy single family office. It serves as the global investment arm of Guangdong Zhonghuan Investment Group, a Chinese conglomerate. The firm invests across various asset classes, including real estate development, venture capital, private equity funds, and debt. Its venture investments are tech-focused, and its real estate portfolio includes residential, commercial, and mixed-use projects in the US and China.
Portfolio Companies
10
Website
onelincapital.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Butlr Technologies | Aug 2024 | Series B | - |
| Lily AI | Mar 2024 | Series B Extension | - |
| Nowports | May 2022 | Series C | - |
| ImmunoVec | Mar 2022 | Seed | Co-investor |
| Avvio Medical | Oct 2021 | Series B | - |
Key People
Leonard Lee
Partner
Shirley Chen
Principal
Junjun Qian
Investor
Judy Lee
GM, Investments, Chief of Staff
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
